
What makes lager yeast special? Inside the genetics of beer
While beers such as ales, stouts and sours have their own fanbases, America has long favored a crisp, refreshing lager. But what makes a yeast variety suitable for light, lager beer rather than ales?
According to , a professor of genetics evolution at the University of Wisconsin–Madison, Saccharomyces cerevisiae, or baker’s yeast, requires a warm environment for optimal fermentation. This works well for brewing heavier beers, such as ales. However, to produce a lager, brewers need yeast that ferments best at cool temperatures.

Industrial lager brewers favor S. pastorianus, a hybrid of S. cerevisiae and a wild ancestor. Scientists did not understand how S. cerevisiae evolved to give rise to a cold-dwelling species until they discovered the wild ancestor of lager yeast, , in 2011.
To understand this evolution, Hittinger’s lab compared the genomes of S. cerevisiae and S. eubayanus and found that S. eubayanus acquired cold tolerance in part through its .
“When we do experiments where we take a strain of industrial lager yeast, all of which have the S. eubayanus mitochondrial genome, and swap in the S. cerevisiae mitochondrial genome, the temperature preference of the yeast shifts upwards,” Hittinger said. “We think this is one of the big smoking guns, and it explains why all industrial lager strains have an S. eubayanus mitochondrial genome.”

Sugar, sugar, sugar
Beer starts with three main components: hops, yeast and wort — a sugary grain water that contains maltose and maltotriose.
“Unless you like cloyingly sweet beers ... you need to ferment all of the fermentable sugars into carbon dioxide and ethanol to create a nice, crisp, dry lager you’d enjoy on a hot summer day,” Hittinger said.
Domesticated lager yeasts can ferment maltotriose, but S. eubayanus cannot. Hittinger, John Crandall, a Ph.D. student in the Hittinger lab, and collaborators performed adaptive evolution experiments to find out how S. eubayanus could have acquired this trait. They found two distinct mechanisms.

“Both of our studies show that it takes pretty dramatic mutations to evolve this key trait,” Crandall said.
When selecting for maltotriose use, they found S. eubayanus acquired a via genetic recombination of two MALT genes, which alone drive maltose metabolism.
Conversely, when they performed experiments selecting for maltose use, they found that the mutant S. eubayanus changed from diploid to . This change activated an alternative metabolism in the yeast cells, allowing a haploid-specific gene to activate a previously dormant sugar transporter.
“Most of the advantage that haploids have comes from the fact that they express a small set of haploid-specific genes, which defines their cell type,” Crandall said. “None of these (haploid) genes were known to have any regulatory crosstalk with metabolic pathways in Saccharomyces cerevisiae, where that cell type–specification circuit has been extensively studied.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.